Diasorin Molecular, LLC
Explore this company’s associated devices, FDA decisions and regulatory history.

Diasorin Molecular, LLC
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Diasorin Molecular, LLC. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 15, 2026 to Jun 15, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code PGX appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 11331 Valley View St., Cypress, CA, 90630, US. Recorded on K260333, decision dated Jun 15, 2026.
Device categories in this collection
Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
LIAISON NES Group A Strep; LIAISON NES Group A Strep Control Swab Kit
K260333 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.